Sourcing guide · research use only
Where to buy tesamorelin for research.
Tesamorelin is a stabilized 44-residue analog of growth-hormone-releasing hormone (GHRH) studied in laboratory research on the GH/IGF-1 axis. It is a longer peptide than most research GH-axis compounds — and chain length changes what a real certificate of analysis has to prove. This guide covers what to verify before buying tesamorelin, why a 44-mer needs a chromatogram and not just a number, and the in-catalog GH-axis option Titan actually documents. It makes no human-use, dosing, or efficacy claims.
Before you buy
What a long-chain peptide COA must prove.
A tesamorelin document has to do everything a short-peptide COA does — and then account for 44 residues’ worth of synthesis impurities. Run any tesamorelin listing against this table before you trust the purity number on it.
| What to check | What a real COA shows | Red flag |
|---|---|---|
| Sequence identity (MS) | Mass spectrometry confirming the full 44-residue GHRH analog — every residue, not a truncated fragment that happens to share a mass window | A purity number with no mass-spec identity, or identity run against a shorter reference sequence |
| Deletion-sequence purity (HPLC) | An HPLC chromatogram with the trace shown — long peptides accumulate deletion and truncation impurities during synthesis, so the chromatogram matters more here than on a short peptide | A bare percentage with no chromatogram; you can't see the impurity peaks a 44-mer is prone to |
| Purity figure | Purity stated against the full-length sequence with the method named (HPLC area %), not a marketing round number | "99%+" with no method, no chromatogram, and no reference to chain length |
| Net peptide content | Peptide content distinguished from salt and water weight, so the labeled mass reflects actual peptide | Gross mg only — common on longer peptides where salt/water inflate the number |
| Lot / batch + compliance | A lot code matching the vial, documentation silent on human use | A generic reused COA, mismatched lot, or human-use / dosing claims |
Tesamorelin is a long-chain GHRH analog
Tesamorelin is a stabilized analog of growth-hormone-releasing hormone — the full GHRH(1-44) sequence with a modification that resists enzymatic breakdown, studied in laboratory research on the GH/IGF-1 axis. At 44 residues it is a markedly longer peptide than the short GH-axis research compounds, and chain length is exactly what makes its purity harder to certify. The longer the peptide, the more synthesis-related impurities a real COA has to rule out.
GH-axis research compounds →Why a tesamorelin COA is harder to fake well
Solid-phase synthesis of a 44-residue peptide accumulates deletion sequences — chains missing one or more residues — that a short HPLC method or a number-only COA will hide. A genuine tesamorelin certificate of analysis shows the chromatogram so the deletion peaks are visible, names the HPLC method, confirms the full-length sequence by mass spectrometry, and separates net peptide content from salt and water. A bare "99%" tells you nothing about the impurities a long peptide is specifically prone to.
How to read a COA →What Titan stocks in the GH-axis space
Titan does not currently list tesamorelin. Rather than sell a compound it does not test in-house, this guide points researchers to the verification standard that applies to any GHRH-class source and to the in-catalog GH-axis option Titan documents: CJC-1295 with Ipamorelin — a modified GHRH(1-29) analog paired with a growth-hormone-releasing peptide, lot-matched to a COA. The mechanism class overlaps; the difference is which one carries documentation you can verify.
CJC-1295 / Ipamorelin →Red flags on tesamorelin listings
Walk away from any tesamorelin source whose documentation carries dosing, weight, lipodystrophy, or other human-use claims — that is a compliance red flag, not a quality spec. Be skeptical of a COA that states a purity number with no chromatogram, identity run against a sequence shorter than 44 residues, gross milligrams with no net peptide content, a single generic document reused across products, or a lot code that doesn't match the vial.
Sourcing research compounds →How Titan fulfills GH-axis research orders
Documented, lot-matched, crypto checkout.
- 1. Verify the document before the molecule. For any GHRH-class compound, confirm the COA shows a chromatogram, names the HPLC method, and confirms identity by mass spectrometry — the longer the chain, the more this matters.
- 2. Lot-matched documentation. Titan’s in-catalog GH-axis option, CJC-1295 with Ipamorelin, ships referenced to a batch code with an HPLC purity target and identity confirmation.
- 3. Crypto-only checkout. USDC, BTC, and SOL accepted; stablecoin keeps the total fixed from cart to on-chain confirmation.
- 4. Verify it yourself. Match the lot code to the vial and read the chromatogram — don’t accept a purity number on a long peptide without one.
Tesamorelin is a stabilized GHRH(1-44) analog studied in laboratory research on the growth-hormone axis. Titan does not currently list it; its documented GH-axis research option is CJC-1295 with Ipamorelin. Everything here is supplied strictly for research use only, with no human-use, dosing, or efficacy claims. This page is about sourcing and verification, not use.
Related reading